{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:40:32Z","timestamp":1792100432998,"version":"4.4.0"},"reference-count":210,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Cardiovasc Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Precision-based percutaneous coronary intervention (PCI) integrates contemporary strategies across the pre-, intra-, and post-procedural phases to improve outcomes and minimize complications. Emerging evidence underscores the value of these strategies in reducing adverse events and improving procedural efficiency. While artificial intelligence and pharmacogenomics hold long-term promise for enhancing personalization, their clinical utility in PCI remains in the early stages of development.<\/jats:p>","DOI":"10.1038\/s44325-026-00111-y","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:04:51Z","timestamp":1774263891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Precision percutaneous coronary intervention"],"prefix":"10.1038","volume":"3","author":[{"given":"Travis M.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzair","family":"Munaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafhat","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Affan","family":"Rizwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyan","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafeez Ul Hassan","family":"Virk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboob","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umair","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzamil","family":"Khawaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanawat","family":"Attachaipanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa H.","family":"Cavallari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Nanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd W.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Mintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chayakrit","family":"Krittanawong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"111_CR1","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41569-019-0261-7","volume":"16","author":"JM Kalman","year":"2019","unstructured":"Kalman, J. M. et al. Looking back and thinking forwards - 15 years of cardiology and cardiovascular research. Nat. Rev. Cardiol. 16, 651\u2013660 (2019).","journal-title":"Nat. Rev. Cardiol."},{"key":"111_CR2","doi-asserted-by":"publisher","first-page":"e005733","DOI":"10.1161\/JAHA.117.005733","volume":"7","author":"AP Amin","year":"2018","unstructured":"Amin, A. P. et al. Novel patient-centered approach to facilitate same-day discharge in patients undergoing elective percutaneous coronary intervention. J. Am. Heart Assoc. 7, e005733 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"111_CR3","first-page":"255","volume":"98","author":"SS Naidu","year":"2021","unstructured":"Naidu, S. S. et al. SCAI expert consensus update on best practices in the cardiac catheterization laboratory. Catheter. Cardiovasc. Interv. 98, 255\u2013276 (2021).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"111_CR4","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1161\/CIR.0000000000000996","volume":"144","author":"S Bangalore","year":"2021","unstructured":"Bangalore, S. et al. Evidence-based practices in the cardiac catheterization laboratory: a scientific statement from the American Heart Association. Circulation 144, e107\u2013e119 (2021).","journal-title":"Circulation"},{"key":"111_CR5","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.jcin.2024.03.033","volume":"17","author":"M Boukantar","year":"2024","unstructured":"Boukantar, M. et al. A randomized controlled trial of nonfasting vs fasting before interventional coronary procedures. TONIC Trial JACC Cardiovasc. Interv. 17, 1200\u20131210 (2024).","journal-title":"TONIC Trial JACC Cardiovasc. Interv."},{"key":"111_CR6","doi-asserted-by":"publisher","unstructured":"Mishra, A. et al. P4599Strict versus no fasting prior to cardiac catheterization: a prospective evaluation of safety and clinical outcomes. Euro. Heart J. 40 https:\/\/doi.org\/10.1093\/eurheartj\/ehz745.0983 (2019).","DOI":"10.1093\/eurheartj\/ehz745.0983"},{"key":"111_CR7","doi-asserted-by":"publisher","first-page":"oead111","DOI":"10.1093\/ehjopen\/oead111","volume":"3","author":"D Ferreira","year":"2023","unstructured":"Ferreira, D. et al. Safety and care of no fasting prior to catheterization laboratory procedures: a non-inferiority randomized control trial protocol (SCOFF trial). Eur. Heart J. Open 3, oead111 (2023).","journal-title":"Eur. Heart J. Open"},{"key":"111_CR8","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.jacc.2013.11.043","volume":"63","author":"BL N\u00f8rgaard","year":"2014","unstructured":"N\u00f8rgaard, B. L. et al. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). J. Am. Coll. Cardiol. 63, 1145\u20131155 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"111_CR9","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1109\/TMI.2018.2883807","volume":"38","author":"M Zreik","year":"2018","unstructured":"Zreik, M. et al. A recurrent CNN for automatic detection and classification of coronary artery plaque and stenosis in coronary CT angiography. IEEE Trans. Med. imaging 38, 1588\u20131598 (2018).","journal-title":"IEEE Trans. Med. imaging"},{"key":"111_CR10","doi-asserted-by":"publisher","first-page":"014003","DOI":"10.1117\/1.JMI.2.1.014003","volume":"2","author":"D Kang","year":"2015","unstructured":"Kang, D. et al. Structured learning algorithm for detection of nonobstructive and obstructive coronary plaque lesions from computed tomography angiography. J. Med. Imaging 2, 014003\u2013014003 (2015).","journal-title":"J. Med. Imaging"},{"key":"111_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jcct.2018.04.011","volume":"12","author":"AR van Rosendael","year":"2018","unstructured":"van Rosendael, A. R. et al. Maximization of the usage of coronary CTA derived plaque information using a machine learning based algorithm to improve risk stratification; insights from the CONFIRM registry. J. Cardiovasc. Comput. Tomogr. 12, 204\u2013209 (2018).","journal-title":"J. Cardiovasc. Comput. Tomogr."},{"key":"111_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.media.2016.04.004","volume":"34","author":"JM Wolterink","year":"2016","unstructured":"Wolterink, J. M. et al. Automatic coronary artery calcium scoring in cardiac CT angiography using paired convolutional neural networks. Med. Image Anal. 34, 123\u2013136 (2016).","journal-title":"Med. Image Anal."},{"key":"111_CR13","first-page":"754","volume":"14","author":"D Venetsanos","year":"2021","unstructured":"Venetsanos, D. et al. Uninterrupted oral anticoagulant therapy in patients undergoing unplanned percutaneous coronary intervention. JACC: Cardiovasc. Interv. 14, 754\u2013763 (2021).","journal-title":"JACC: Cardiovasc. Interv."},{"key":"111_CR14","doi-asserted-by":"publisher","first-page":"e008274","DOI":"10.1161\/CIRCINTERVENTIONS.119.008274","volume":"13","author":"MW Sherwood","year":"2020","unstructured":"Sherwood, M. W. et al. Outcomes of cardiac catheterization in patients with atrial fibrillation on anticoagulation in contemporary in practice. Circ. Cardiovasc. Interv. 13, e008274 (2020).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"111_CR15","first-page":"549","volume":"46","author":"XJ Zhang","year":"2018","unstructured":"Zhang, X. J. et al. Comparison of safety between continued warfarin therapy and bridging anticoagulation therapy in patients undergoing coronary intervention]. Zhonghua Xin Xue Guan Bing. Za Zhi 46, 549\u2013553 (2018).","journal-title":"Zhonghua Xin Xue Guan Bing. Za Zhi"},{"key":"111_CR16","first-page":"627","volume":"30","author":"S Lavi","year":"2014","unstructured":"Lavi, S. et al. Sedation, analgesia, and anaesthesia variability in laboratory-based cardiac procedures: an international survey. Can. J. Cardiol. 30, 627\u2013633 (2014).","journal-title":"Can. J. Cardiol."},{"key":"111_CR17","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/01.JCN.0000297386.14002.f2","volume":"22","author":"J Woodhead","year":"2007","unstructured":"Woodhead, J., Harding, S. A., Simmonds, M., Dee, S. & McBride-Henry, K. Premedication for cardiac catheterization and percutaneous coronary intervention: does it increase vascular access site complications? J. Cardiovasc. Nurs. 22, 466\u2013471 (2007).","journal-title":"J. Cardiovasc. Nurs."},{"issue":"Suppl 4","key":"111_CR18","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.47391\/JPMA.EGY-S4-22","volume":"73","author":"MM Elattar","year":"2023","unstructured":"Elattar, M. M., NBiomy, R., Haseeb, W. A. & Salama, M. K. Topical lidocaine and or\/ intravenous midazolam before radial coronary angiography to prevent radial artery spasm. J. Pak. Med .Assoc. 73(Suppl 4), S103\u2013s108 (2023).","journal-title":"J. Pak. Med .Assoc."},{"key":"111_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jcin.2012.11.005","volume":"6","author":"S Deftereos","year":"2013","unstructured":"Deftereos, S. et al. Moderate procedural sedation and opioid analgesia during transradial coronary interventions to prevent spasm: a prospective randomized study. JACC Cardiovasc. Interv. 6, 267\u2013273 (2013).","journal-title":"JACC Cardiovasc. Interv."},{"key":"111_CR20","doi-asserted-by":"publisher","unstructured":"Mall, A. et al. Timing of sedation and patient-reported pain outcomes during cardiac catheterization: Results from the UNTAP-intervention study. Catheter. Cardiovasc. Interv. https:\/\/doi.org\/10.1002\/ccd.30535 (2023).","DOI":"10.1002\/ccd.30535"},{"key":"111_CR21","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","volume":"371","author":"Montalescot","year":"2014","unstructured":"Montalescot et al. Prehospital ticagrelor in ST-segment elevation myocardial infarction. N. Engl. J. Med. 371, 1016\u20131027 (2014).","journal-title":"N. Engl. J. Med."},{"key":"111_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1161\/CIRCULATIONAHA.117.031678","volume":"137","author":"JW McEvoy","year":"2018","unstructured":"McEvoy, J. W. et al. Effect of Intravenous fentanyl on ticagrelor absorption and platelet inhibition among patients undergoing percutaneous coronary intervention. Circulation 137, 307\u2013309 (2018).","journal-title":"Circulation"},{"key":"111_CR23","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.119.042816","volume":"141","author":"M Saad","year":"2020","unstructured":"Saad, M. et al. Impact of morphine treatment with and without metoclopramide coadministration on ticagrelor-induced platelet inhibition in acute myocardial infarction. Circulation 141, 1354\u20131356 (2020).","journal-title":"Circulation"},{"key":"111_CR24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.25270\/jic\/20.00132","volume":"32","author":"R Ebrahimi","year":"2020","unstructured":"Ebrahimi, R., Shroyer, A. L., Dennis, P., Currier, J. & Lendvai Wischik, D. Music can reduce the need for pharmacologic conscious sedation during invasive coronary angiography. J. Invasive Cardiol. 32, 440\u2013444 (2020).","journal-title":"J. Invasive Cardiol."},{"key":"111_CR25","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1007\/s11033-010-0446-y","volume":"38","author":"S Ya\u011far","year":"2011","unstructured":"Ya\u011far, S., Yava\u015f, S. & Karahalil, B. The role of the ADRA2A C1291G genetic polymorphism in response to dexmedetomidine on patients undergoing coronary artery surgery. Mol. Biol. Rep. 38, 3383\u20133389 (2011).","journal-title":"Mol. Biol. Rep."},{"key":"111_CR26","doi-asserted-by":"publisher","first-page":"1187415","DOI":"10.3389\/fgene.2023.1187415","volume":"14","author":"Y Ding","year":"2023","unstructured":"Ding, Y. et al. Genetic polymorphisms are associated with individual susceptibility to dexmedetomidine. Front. Genet. 14, 1187415 (2023).","journal-title":"Front. Genet."},{"key":"111_CR27","doi-asserted-by":"publisher","first-page":"e000035","DOI":"10.1161\/HCV.0000000000000035","volume":"11","author":"PJ Mason","year":"2018","unstructured":"Mason, P. J. et al. An update on radial artery access and best practices for transradial coronary angiography and intervention in acute coronary syndrome: a scientific statement from the American Heart Association. Circ. Cardiovasc. Interv. 11, e000035 (2018).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"111_CR28","first-page":"1387","volume":"97","author":"M Chiarito","year":"2021","unstructured":"Chiarito, M. et al. Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials. Catheter. Cardiovasc. Inter. 97, 1387\u20131396 (2021).","journal-title":"Catheter. Cardiovasc. Inter."},{"key":"111_CR29","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0022-5223(19)42229-0","volume":"61","author":"PW Armstrong","year":"1971","unstructured":"Armstrong, P. W. & Parker, J. O. The complications of brachial arteriotomy. J. Thorac. Cardiovasc. Surg. 61, 424\u2013429 (1971).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"111_CR30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0741-5214(86)90230-2","volume":"4","author":"CH McCollum","year":"1986","unstructured":"McCollum, C. H. & Mavor, E. Brachial artery injury after cardiac catheterization. J. Vasc. Surg. 4, 355\u2013359 (1986).","journal-title":"J. Vasc. Surg."},{"key":"111_CR31","doi-asserted-by":"crossref","unstructured":"Mele, M. et al. How brachial access compares to femoral access for invasive cardiac angiography when radial access is not feasible: a meta-analysis. J. Vasc. Access. 25, 1063\u20131068 (2024).","DOI":"10.1177\/11297298221145752"},{"key":"111_CR32","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0735-1097(97)00064-8","volume":"29","author":"F Kiemeneij","year":"1997","unstructured":"Kiemeneij, F., Laarman, G. J., Odekerken, D., Slagboom, T. & van der Wieken, R. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. J. Am. Coll. Cardiol. 29, 1269\u20131275 (1997).","journal-title":"J. Am. Coll. Cardiol."},{"key":"111_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.carrev.2022.09.006","volume":"46","author":"A Isath","year":"2023","unstructured":"Isath, A. et al. A meta-analysis of traditional radial access and distal radial access in transradial access for percutaneous coronary procedures. Cardiovasc. Revasc. Med 46, 21\u201326 (2023).","journal-title":"Cardiovasc. Revasc. Med"},{"key":"111_CR34","doi-asserted-by":"publisher","unstructured":"Elwany, M., Dawood, M., Shakhlab, A., Sadaka, M. & Sobhy M. Current alternatives to traditional radial approach for coronary interventions: a randomized prospective study of the ulnar and distal radial approaches. Catheter. Cardiovasc. Interv. https:\/\/doi.org\/10.1002\/ccd.31071 (2024).","DOI":"10.1002\/ccd.31071"},{"key":"111_CR35","first-page":"295","volume":"24","author":"WM Suh","year":"2012","unstructured":"Suh, W. M. & Kern, M. J. Coronary and bypass graft angiography via the right radial approach using a single catheter. J. Invasive Cardiol. 24, 295\u2013297 (2012).","journal-title":"J. Invasive Cardiol."},{"key":"111_CR36","first-page":"316","volume":"80","author":"T Patel","year":"2012","unstructured":"Patel, T., Shah, S. & Patel, T. Cannulating LIMA graft using right transradial approach: two simple and innovative techniques. Catheter Cardiovasc. Inter. 80, 316\u2013320 (2012).","journal-title":"Catheter Cardiovasc. Inter."},{"key":"111_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.carrev.2022.06.001","volume":"44","author":"A Colombo","year":"2022","unstructured":"Colombo, A. et al. Comparing left internal mammary angiography via right radial or femoral access with a single-catheter technique. Cardiovasc. Revasc. Med. 44, 21\u201329 (2022).","journal-title":"Cardiovasc. Revasc. Med."},{"key":"111_CR38","first-page":"188","volume":"56","author":"KS Cha","year":"2002","unstructured":"Cha, K. S. & Kim, M. H. Feasibility and safety of concomitant left internal mammary arteriography at the setting of the right transradial coronary angiography. Catheter. Cardiovasc. Interv. 56, 188\u2013195 (2002).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"111_CR39","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/heartjnl-2012-302895","volume":"99","author":"M Dominici","year":"2013","unstructured":"Dominici, M. et al. Operator exposure to x-ray in left and right radial access during percutaneous coronary procedures: OPERA randomised study. Heart 99, 480\u2013484 (2013).","journal-title":"Heart"},{"key":"111_CR40","first-page":"1027","volume":"88","author":"RM Shah","year":"2016","unstructured":"Shah, R. M., Patel, D., Abbate, A., Cowley, M. J. & Jovin, I. S. Comparison of transradial coronary procedures via right radial versus left radial artery approach: a meta-analysis. Catheter. Cardiovasc. Interv. 88, 1027\u20131033 (2016).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"111_CR41","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.jcin.2013.08.004","volume":"6","author":"TT Michael","year":"2013","unstructured":"Michael, T. T. et al. A randomized comparison of the transradial and transfemoral approaches for coronary artery bypass graft angiography and intervention: the RADIAL-CABG Trial (RADIAL versus femoral access for coronary artery bypass graft angiography and intervention). JACC Cardiovasc. Interv. 6, 1138\u20131144 (2013).","journal-title":"JACC Cardiovasc. Interv."},{"key":"111_CR42","doi-asserted-by":"publisher","unstructured":"Hamilton, G. W. et al. Ultrasound guidance for transradial access in the cardiac catheterisation laboratory: a systematic review of the literature and meta-analysis. Heart Lung Circ. https:\/\/doi.org\/10.1016\/j.hlc.2024.04.308 (2024).","DOI":"10.1016\/j.hlc.2024.04.308"},{"key":"111_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4244\/EIJ-D-22-00809","volume":"20","author":"MA d\u2019Entremont","year":"2024","unstructured":"d\u2019Entremont, M. A. et al. Ultrasound guidance for transfemoral access in coronary procedures: an individual participant-level data metaanalysis from the femoral ultrasound trialist collaboration. EuroIntervention 20, 66\u201374 (2024).","journal-title":"EuroIntervention"},{"key":"111_CR44","doi-asserted-by":"crossref","unstructured":"d\u2019Entremont, M. A. et al. Ultrasound-guided transfemoral access for coronary procedures: a pooled learning curve analysis from the FAUST and UNIVERSAL Trials. Circ. Cardiovasc. Interv. 17, e013817 (2024).","DOI":"10.1161\/CIRCINTERVENTIONS.123.013817"},{"key":"111_CR45","first-page":"124","volume":"105","author":"M Yoshinaga","year":"2025","unstructured":"Yoshinaga, M., Muramatsu, T., Higami, H. & Nasu, K. Pre-procedural virtual reality guiding catheter simulation navigating successful percutaneous coronary intervention of a chronic total occlusion of an anomalous origin of the right coronary artery. Catheter. Cardiovasc. Interv. 105, 124\u2013130 (2025).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"111_CR46","doi-asserted-by":"publisher","first-page":"107540","DOI":"10.1016\/j.compbiomed.2023.107540","volume":"166","author":"T Yao","year":"2023","unstructured":"Yao, T. et al. Enhancing percutaneous coronary intervention with heuristic path planning and deep-learning-based vascular segmentation. Comput. Biol. Med. 166, 107540 (2023).","journal-title":"Comput. Biol. Med."},{"key":"111_CR47","first-page":"865","volume":"12","author":"RC Gosling","year":"2019","unstructured":"Gosling, R. C. et al. Virtual coronary intervention: a treatment planning tool based upon the angiogram. JACC: Cardiovasc. Imaging 12, 865\u2013872 (2019).","journal-title":"JACC: Cardiovasc. Imaging"},{"key":"111_CR48","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/clc.23906","volume":"45","author":"B Abdelazeem","year":"2022","unstructured":"Abdelazeem, B. et al. The efficacy of nitroglycerin to prevent radial artery spasm and occlusion during and after transradial catheterization: a systematic review and meta-analysis of randomized controlled trials. Clin. Cardiol. 45, 1171\u20131183 (2022).","journal-title":"Clin. Cardiol."},{"key":"111_CR49","first-page":"180","volume":"17","author":"M Beyranvand","year":"2022","unstructured":"Beyranvand, M., Mohammadi, Z., Asadpour Piranfar, M. & Gachkar, L. Effects of verapamil on the reduction of radial artery thrombosis after coronary angiography: a randomized clinical trial. J. Tehran Heart Cent. 17, 180\u2013185 (2022).","journal-title":"J. Tehran Heart Cent."},{"key":"111_CR50","doi-asserted-by":"publisher","first-page":"1007147","DOI":"10.3389\/fcvm.2023.1007147","volume":"10","author":"OH Lee","year":"2023","unstructured":"Lee, O. H. et al. Comparison of spasmolytic regimen for prevention of radial artery spasm during the distal radial approach: a single-center, randomized study. Front. Cardiovasc. Med. 10, 1007147 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"111_CR51","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.amjcard.2022.11.005","volume":"188","author":"N Bouchahda","year":"2023","unstructured":"Bouchahda, N. et al. Combination therapy with nicardipine and isosorbide dinitrate to prevent spasm in transradial percutaneous coronary intervention (from the NISTRA multicenter double-blind randomized controlled trial). Am. J. Cardiol. 188, 89\u201394 (2023).","journal-title":"Am. J. Cardiol."},{"key":"111_CR52","first-page":"654","volume":"76","author":"S Plante","year":"2010","unstructured":"Plante, S. et al. Comparison of bivalirudin versus heparin on radial artery occlusion after transradial catheterization. Catheter. Cardiovasc. Inter. 76, 654\u2013658 (2010).","journal-title":"Catheter. Cardiovasc. Inter."},{"key":"111_CR53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jcin.2011.08.011","volume":"5","author":"M Uhlemann","year":"2012","unstructured":"Uhlemann, M. et al. The Leipzig prospective vascular ultrasound registry in radial artery catheterization: impact of sheath size on vascular complications. JACC Cardiovasc. Inter. 5, 36\u201343 (2012).","journal-title":"JACC Cardiovasc. Inter."},{"key":"111_CR54","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jcin.2010.03.009","volume":"3","author":"S Rathore","year":"2010","unstructured":"Rathore, S. et al. Impact of length and hydrophilic coating of the introducer sheath on radial artery spasm during transradial coronary intervention: a randomized study. JACC Cardiovasc. Interv. 3, 475\u2013483 (2010).","journal-title":"JACC Cardiovasc. Interv."},{"key":"111_CR55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00059-018-4707-1","volume":"45","author":"B Gul","year":"2020","unstructured":"Gul, B. et al. Comparison of procedural success between two radial sheaths : comparison of the 6-Fr Glidesheath Slender to 6-Fr standard sheath. Herz 45, 79\u201385 (2020).","journal-title":"Herz"},{"key":"111_CR56","first-page":"51","volume":"86","author":"R Cheaito","year":"2015","unstructured":"Cheaito, R. et al. Feasibility and safety of transradial coronary interventions using a 6.5-F sheathless guiding catheter in patients with small radial arteries. Catheter. Cardiovasc. Inter. 86, 51\u201358 (2015).","journal-title":"Catheter. Cardiovasc. Inter."},{"key":"111_CR57","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.carrev.2023.11.011","volume":"61","author":"T Yamada","year":"2024","unstructured":"Yamada, T. et al. Efficacy and safety of sheathless guiding catheter for distal radial approach. Cardiovasc. Revascularization Med. 61, 64\u201367 (2024).","journal-title":"Cardiovasc. Revascularization Med."},{"key":"111_CR58","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.amjcard.2022.09.007","volume":"185","author":"L Azzalini","year":"2022","unstructured":"Azzalini, L. et al. Impact of left ventricular end-diastolic pressure on the outcomes of patients undergoing percutaneous coronary intervention. Am. J. Cardiol. 185, 107\u2013114 (2022).","journal-title":"Am. J. Cardiol."},{"key":"111_CR59","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijcard.2020.01.064","volume":"306","author":"C Liu","year":"2020","unstructured":"Liu, C., Caughey, M. C., Smith, S. C. & Dai, X. Elevated left ventricular end diastolic pressure is associated with increased risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. Int. J. Cardiol. 306, 196\u2013202 (2020).","journal-title":"Int. J. Cardiol."},{"key":"111_CR60","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/S0140-6736(14)60689-9","volume":"383","author":"SS Brar","year":"2014","unstructured":"Brar, S. S. et al. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial. Lancet 383, 1814\u20131823 (2014).","journal-title":"Lancet"},{"key":"111_CR61","doi-asserted-by":"publisher","first-page":"6526270","DOI":"10.1155\/2021\/6526270","volume":"2021","author":"G Gu","year":"2021","unstructured":"Gu, G., Liu, D., Lu, R. & Cui, W. Left ventricular end-diastolic pressure and B-Type natriuretic peptide levels guidance of low-dose furosemide treatment to prevent contrast-induced nephropathy in patients with percutaneous coronary intervention: a randomized controlled trial. J. Interv. Cardiol. 2021, 6526270 (2021).","journal-title":"J. Interv. Cardiol."},{"key":"111_CR62","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000350648","volume":"125","author":"G-Q Gu","year":"2013","unstructured":"Gu, G.-Q. et al. Low-dose furosemide administered with adequate hydration reduces contrast-induced nephropathy in patients undergoing coronary angiography. Cardiology 125, 69\u201373 (2013).","journal-title":"Cardiology"},{"key":"111_CR63","first-page":"2542","volume":"13","author":"M Barbanti","year":"2020","unstructured":"Barbanti, M. et al. Coronary cannulation after transcatheter aortic valve replacement. JACC: Cardiovasc. Interv. 13, 2542\u20132555 (2020).","journal-title":"JACC: Cardiovasc. Interv."},{"key":"111_CR64","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s00392-015-0824-5","volume":"104","author":"J Blumenstein","year":"2015","unstructured":"Blumenstein, J. et al. Challenges of coronary angiography and intervention in patients previously treated by TAVI. Clin. Res. Cardiol. 104, 632\u2013639 (2015).","journal-title":"Clin. Res. Cardiol."},{"key":"111_CR65","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jacc.2015.10.103","volume":"67","author":"T Chakravarty","year":"2016","unstructured":"Chakravarty, T. et al. Outcomes in Patients With Transcatheter Aortic Valve Replacement and Left Main Stenting: The TAVR-LM Registry. J. Am. Coll. Cardiol. 67, 951\u2013960 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"111_CR66","first-page":"361","volume":"25","author":"G Greenberg","year":"2013","unstructured":"Greenberg, G. & Kornowski, R. Coronary angioplasty after self-expandable transcatheter aortic valve implantation. J. Invasive Cardiol. 25, 361\u2013363 (2013).","journal-title":"J. Invasive Cardiol."},{"key":"111_CR67","doi-asserted-by":"publisher","first-page":"e006556","DOI":"10.1161\/CIRCINTERVENTIONS.118.006556","volume":"11","author":"J Shamekhi","year":"2018","unstructured":"Shamekhi, J. & Sinning, J.-M. Complete revascularization in patients before undergoing transcatheter aortic valve replacement. Circ. Cardiovasc. Interv. 11, e006556 (2018).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"111_CR68","first-page":"E527","volume":"96","author":"S Nazir","year":"2020","unstructured":"Nazir, S. et al. Incidence, outcomes, and predictors of in-hospital acute coronary syndrome following endovascular transcatheter aortic valve replacement in the United States. Catheter. Cardiovasc. Interv. 96, E527\u2013e534 (2020).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"111_CR69","first-page":"1965","volume":"14","author":"T Patterson","year":"2021","unstructured":"Patterson, T. et al. ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION). JACC: Cardiovasc. Interv. 14, 1965\u20131974 (2021).","journal-title":"JACC: Cardiovasc. Interv."},{"key":"111_CR70","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.amjcard.2019.08.024","volume":"124","author":"N Lateef","year":"2019","unstructured":"Lateef, N. et al. Meta-analysis comparing outcomes in patients undergoing transcatheter aortic valve implantation with versus without percutaneous coronary intervention. Am. J. Cardiol. 124, 1757\u20131764 (2019).","journal-title":"Am. J. Cardiol."},{"key":"111_CR71","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jcin.2020.01.216","volume":"13","author":"T Ochiai","year":"2020","unstructured":"Ochiai, T. et al. Coronary access after TAVR. JACC Cardiovasc. Inter. 13, 693\u2013705 (2020).","journal-title":"JACC Cardiovasc. Inter."},{"key":"111_CR72","first-page":"331","volume":"11","author":"KG Chua","year":"1985","unstructured":"Chua, K. G., Feldman, T. & Fromes, B. Relief of pressure damping during coronary angioplasty: a device for creating side holes in ptca guiding catheters. Catheter. Cardiovasc. Diagn. 11, 331\u2013333 (1985).","journal-title":"Catheter. Cardiovasc. Diagn."},{"key":"111_CR73","first-page":"306","volume":"28","author":"KS Patel","year":"2016","unstructured":"Patel, K. S. et al. Prospective evaluation of the impact of side-holes and guide-catheter disengagement from the coronary ostium on fractional flow reserve measurements. J. Invasive Cardiol. 28, 306\u2013310 (2016).","journal-title":"J. Invasive Cardiol."},{"key":"111_CR74","first-page":"145","volume":"33","author":"B De Bruyne","year":"1994","unstructured":"De Bruyne, B., Stockbroeckx, J., Demoor, D., Heyndrickx, G. R. & Kern, M. J. Role of side holes in guide catheters: observations on coronary pressure and flow. Cathet Cardiovasc. Diagn. 33, 145\u2013152 (1994).","journal-title":"Cathet Cardiovasc. Diagn."},{"key":"111_CR75","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/CIRCOUTCOMES.110.960385","volume":"5","author":"JP Curtis","year":"2012","unstructured":"Curtis, J. P. et al. Use and effectiveness of intra-aortic balloon pumps among patients undergoing high risk percutaneous coronary intervention: insights from the national cardiovascular data registry. Circ. Cardiovasc. Qual. Outcomes 5, 21\u201330 (2012).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"111_CR76","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.112.098194","volume":"126","author":"WW O\u2019Neill","year":"2012","unstructured":"O\u2019Neill, W. W. et al. A prospective, randomized clinical trial of hemodynamic support with impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention. Circulation 126, 1717\u20131727 (2012).","journal-title":"Circulation"},{"key":"111_CR77","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.amjcard.2022.08.032","volume":"185","author":"AJ Lansky","year":"2022","unstructured":"Lansky, A. J. et al. Impella versus intra-aortic balloon pump for high-risk PCI: a propensity-adjusted large-scale claims dataset analysis. Am. J. Cardiol. 185, 29\u201336 (2022).","journal-title":"Am. J. Cardiol."},{"key":"111_CR78","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ahj.2022.02.006","volume":"248","author":"WW O\u2019Neill","year":"2022","unstructured":"O\u2019Neill, W. W. et al. Improved outcomes in patients with severely depressed LVEF undergoing percutaneous coronary intervention with contemporary practices. Am. Heart J. 248, 139\u2013149 (2022).","journal-title":"Am. Heart J."},{"key":"111_CR79","first-page":"207","volume":"10","author":"KJ Kunkel","year":"2021","unstructured":"Kunkel, K. J., Dabbagh, M. F., Zaidan, M. & Alaswad, K. Mechanical circulatory support in high-risk percutaneous coronary intervention. Inter. Cardiol. Clin. 10, 207\u2013219 (2021).","journal-title":"Inter. Cardiol. Clin."},{"key":"111_CR80","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.jacc.2015.03.036","volume":"65","author":"CS Rihal","year":"2015","unstructured":"Rihal, C. S. et al. 2015 SCAI\/ACC\/HFSA\/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d\u2019intervention. J. Am. Coll. Cardiol. 65, e7\u2013e26 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"111_CR81","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.amjcard.2016.05.003","volume":"118","author":"A Briasoulis","year":"2016","unstructured":"Briasoulis, A. et al. Meta-analysis of usefulness of percutaneous left ventricular assist devices for high-risk percutaneous coronary interventions. Am. J. Cardiol. 118, 369\u2013375 (2016).","journal-title":"Am. J. Cardiol."},{"key":"111_CR82","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8167011","volume":"2022","author":"DM Van Den Buijs","year":"2022","unstructured":"Van Den Buijs, D. M. et al. Prophylactic impella CP versus VA-ECMO in patients undergoing complex high-risk indicated PCI. J. Interv. Cardiol. 2022, 8167011 (2022).","journal-title":"J. Interv. Cardiol."},{"key":"111_CR83","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/MAT.0b013e31820e121c","volume":"57","author":"D Kawashima","year":"2011","unstructured":"Kawashima, D. et al. Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. ASAIO J. 57, 169\u2013176 (2011).","journal-title":"ASAIO J."},{"key":"111_CR84","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.1540-8191.2011.01338.x","volume":"26","author":"MS Koeckert","year":"2011","unstructured":"Koeckert, M. S., Jorde, U. P., Naka, Y., Moses, J. W. & Takayama, H. Impella LP 2.5 for left ventricular unloading during venoarterial extracorporeal membrane oxygenation support. J. Card. Surg. 26, 666\u2013668 (2011).","journal-title":"J. Card. Surg."},{"key":"111_CR85","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ahj.2021.05.017","volume":"240","author":"R Bajaj","year":"2021","unstructured":"Bajaj, R. et al. Computerized technologies informing cardiac catheterization and guiding coronary intervention. Am. Heart J. 240, 28\u201345 (2021).","journal-title":"Am. Heart J."},{"key":"111_CR86","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/MCA.0000000000001305","volume":"34","author":"E Ben-Assa","year":"2023","unstructured":"Ben-Assa, E. et al. Performance of a novel artificial intelligence software developed to derive coronary fractional flow reserve values from diagnostic angiograms. Coron. Artery Dis. 34, 533\u2013541 (2023).","journal-title":"Coron. Artery Dis."},{"key":"111_CR87","first-page":"488","volume":"13","author":"G Witberg","year":"2020","unstructured":"Witberg, G. et al. Diagnostic performance of angiogram-derived fractional flow reserve: a pooled analysis of 5 prospective cohort studies. Cardiovasc. Interv. 13, 488\u2013497 (2020).","journal-title":"Cardiovasc. Interv."},{"key":"111_CR88","first-page":"2479","volume":"16","author":"S Samant","year":"2023","unstructured":"Samant, S. et al. Artificial intelligence, computational simulations, and extended reality in cardiovascular interventions. Cardiovasc. Interv. 16, 2479\u20132497 (2023).","journal-title":"Cardiovasc. Interv."},{"key":"111_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-023-00880-1","volume":"6","author":"R Avram","year":"2023","unstructured":"Avram, R. et al. CathAI: fully automated coronary angiography interpretation and stenosis estimation. NPJ Digital Med. 6, 142 (2023).","journal-title":"NPJ Digital Med."},{"key":"111_CR90","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4244\/EIJ-D-20-01355","volume":"17","author":"M Chu","year":"2021","unstructured":"Chu, M. et al. Artificial intelligence and optical coherence tomography for the automatic characterisation of human atherosclerotic plaques: AI and OCT for plaque characterisation. EuroIntervention 17, 41 (2021).","journal-title":"EuroIntervention"},{"key":"111_CR91","volume":"1","author":"Y Katagiri","year":"2022","unstructured":"Katagiri, Y. et al. Artificial intelligence vs visual assessment of calcified plaque in coronary artery using optical coherence tomography. JACC: Adv. 1, 100080 (2022).","journal-title":"JACC: Adv."},{"key":"111_CR92","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.120.009840","volume":"14","author":"W Yu","year":"2021","unstructured":"Yu, W. et al. Accuracy of intravascular ultrasound-based fractional flow reserve in identifying hemodynamic significance of coronary stenosis. Circ. Cardiovasc. Interv. 14, e009840 (2021).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"111_CR93","first-page":"30","volume":"92","author":"DM Leistner","year":"2018","unstructured":"Leistner, D. M. et al. Real-time optical coherence tomography coregistration with angiography in percutaneous coronary intervention\u2013impact on physician decision-making: The OPTICO-integration study. Catheter. Cardiovasc. Interv. 92, 30\u201337 (2018).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"111_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-018-0333-x","volume":"23","author":"K Piayda","year":"2018","unstructured":"Piayda, K. et al. Dynamic coronary roadmapping during percutaneous coronary intervention: a feasibility study. Eur. J. Med. Res. 23, 36 (2018).","journal-title":"Eur. J. Med. Res."},{"key":"111_CR95","doi-asserted-by":"publisher","first-page":"E197","DOI":"10.21037\/jtd.2017.03.08","volume":"9","author":"R Jia","year":"2017","unstructured":"Jia, R., Jin, Z., Li, H. & Han, J. Re-crossing the distal cell in bifurcation verified by using an enhanced stent visualization system and optical coherence tomography: a report of two cases. J. Thorac. Dis. 9, E197 (2017).","journal-title":"J. Thorac. Dis."},{"key":"111_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00380-011-0202-9","volume":"28","author":"N Tanaka","year":"2013","unstructured":"Tanaka, N. et al. Assessment of optimum stent deployment by stent boost imaging: comparison with intravascular ultrasound. Heart Vessels 28, 1\u20136 (2013).","journal-title":"Heart Vessels"},{"key":"111_CR97","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4244\/EIJ-D-21-00145","volume":"17","author":"R Beyar","year":"2021","unstructured":"Beyar, R. et al. Robotics, imaging, and artificial intelligence in the catheterisation laboratory: cath lab robotics, imaging, and AI. EuroIntervention 17, 537 (2021).","journal-title":"EuroIntervention"},{"key":"111_CR98","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIRCULATIONAHA.121.057538","volume":"145","author":"JS Lawton","year":"2022","unstructured":"Lawton, J. S. et al. 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145, e18\u2013e114 (2022).","journal-title":"Circulation"},{"key":"111_CR99","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints, C. et al. 2024 ESC guidelines for the management of chronic coronary syndromes: developed by the task force for the management of chronic coronary syndromes of the European Society of Cardiology (ESC) endorsed by the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 45, 3415\u20133537 (2024).","journal-title":"Eur. Heart J."},{"key":"111_CR100","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1056\/NEJMoa2216607","volume":"388","author":"JM Lee","year":"2023","unstructured":"Lee, J. M. et al. Intravascular imaging\u2013guided or angiography-guided complex PCI. N. Engl. J. Med. 388, 1668\u20131679 (2023).","journal-title":"N. Engl. J. Med."},{"key":"111_CR101","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1093\/eurheartj\/ehv367","volume":"36","author":"W Wijns","year":"2015","unstructured":"Wijns, W. et al. Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study. Eur. Heart J. 36, 3346\u20133355 (2015).","journal-title":"Eur. Heart J."},{"key":"111_CR102","doi-asserted-by":"publisher","unstructured":"Riley, R. F. et al. SCAI expert consensus statement on the management of calcified coronary lesions. J. Soc. Cardiovasc. Angiogr. Interv. 3. https:\/\/doi.org\/10.1016\/j.jscai.2023.101259 (2024).","DOI":"10.1016\/j.jscai.2023.101259"},{"key":"111_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-7120-6-24","volume":"6","author":"JR Arnold","year":"2008","unstructured":"Arnold, J. R., West, N. E., van Gaal, W. J., Karamitsos, T. D. & Banning, A. P. The role of intravascular ultrasound in the management of spontaneous coronary artery dissection. Cardiovasc. Ultrasound 6, 1\u20137 (2008).","journal-title":"Cardiovasc. Ultrasound"},{"key":"111_CR104","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.carrev.2016.09.005","volume":"18","author":"MM Mahmood","year":"2017","unstructured":"Mahmood, M. M. & Austin, D. IVUS and OCT guided primary percutaneous coronary intervention for spontaneous coronary artery dissection with bioresorbable vascular scaffolds. Cardiovasc. Revascularization Med. 18, 53\u201357 (2017).","journal-title":"Cardiovasc. Revascularization Med."},{"key":"111_CR105","first-page":"37","volume":"5","author":"A Yip","year":"2015","unstructured":"Yip, A. & Saw, J. Spontaneous coronary artery dissection\u2014a review. Cardiovasc. Diagnosis Ther. 5, 37 (2015).","journal-title":"Cardiovasc. Diagnosis Ther."},{"key":"111_CR106","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.3390\/jcm12062129","volume":"12","author":"I Borzillo","year":"2023","unstructured":"Borzillo, I. et al. Role of intracoronary imaging in myocardial infarction with non-obstructive coronary disease (MINOCA): a review. J. Clin. Med. 12, 2129 (2023).","journal-title":"J. Clin. Med."},{"key":"111_CR107","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.carrev.2018.07.011","volume":"20","author":"MH Yamamoto","year":"2019","unstructured":"Yamamoto, M. H. et al. Optical coherence tomography assessment of morphological characteristics in suspected coronary artery disease, but angiographically nonobstructive lesions. Cardiovasc. Revascularization Med. 20, 475\u2013479 (2019).","journal-title":"Cardiovasc. Revascularization Med."},{"key":"111_CR108","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.120.052008","volume":"143","author":"HR Reynolds","year":"2021","unstructured":"Reynolds, H. R. et al. Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine underlying causes of myocardial infarction with nonobstructive coronary arteries in women. Circulation 143, 624\u2013640 (2021).","journal-title":"Circulation"},{"key":"111_CR109","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.3390\/jcm10132759","volume":"10","author":"K Bryniarski","year":"2021","unstructured":"Bryniarski, K. et al. OCT findings in MINOCA. J. Clin. Med. 10, 2759 (2021).","journal-title":"J. Clin. Med."},{"key":"111_CR110","doi-asserted-by":"publisher","first-page":"e007415","DOI":"10.1161\/CIRCINTERVENTIONS.118.007415","volume":"11","author":"M Abdel-Wahab","year":"2018","unstructured":"Abdel-Wahab, M. et al. High-speed rotational atherectomy versus modified balloons prior to drug-eluting stent implantation in severely calcified coronary lesions. Circ. Cardiovasc. Interv. 11, e007415 (2018).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"111_CR111","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1093\/eurheartj\/ehad342","volume":"44","author":"E Barbato","year":"2023","unstructured":"Barbato, E. et al. Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group. Eur. Heart J. 44, 4340\u20134356 (2023).","journal-title":"Eur. Heart J."},{"key":"111_CR112","first-page":"1024","volume":"86","author":"AS Kini","year":"2015","unstructured":"Kini, A. S. et al. Optical coherence tomography assessment of the mechanistic effects of rotational and orbital atherectomy in severely calcified coronary lesions. Catheter. Cardiovasc. Interv. 86, 1024\u20131032 (2015).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"111_CR113","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/joic.12511","volume":"31","author":"PM Meraj","year":"2018","unstructured":"Meraj, P. M., Shlofmitz, E., Kaplan, B., Jauhar, R. & Doshi, R. Clinical outcomes of atherectomy prior to percutaneous coronary intervention: a comparison of outcomes following rotational versus orbital atherectomy (COAP-PCI study). J. Interv. Cardiol. 31, 478\u2013485 (2018).","journal-title":"J. Interv. Cardiol."},{"key":"111_CR114","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1161\/01.CIR.103.18.2310","volume":"103","author":"EM Antman","year":"2001","unstructured":"Antman, E. M. The search for replacements for unfractionated heparin. Circulation 103, 2310\u20132314 (2001).","journal-title":"Circulation"},{"key":"111_CR115","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0140-6736(11)60876-3","volume":"378","author":"G Montalescot","year":"2011","unstructured":"Montalescot, G. et al. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial. Lancet 378, 693\u2013703 (2011).","journal-title":"Lancet"},{"key":"111_CR116","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ihj.2016.01.014","volume":"68","author":"S Ali-Hassan-Sayegh","year":"2016","unstructured":"Ali-Hassan-Sayegh, S. et al. Administration of low molecular weight and unfractionated heparin during percutaneous coronary intervention. Indian Heart J. 68, 213\u2013224 (2016).","journal-title":"Indian Heart J."},{"key":"111_CR117","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.jcin.2022.05.047","volume":"15","author":"M Didagelos","year":"2022","unstructured":"Didagelos, M. et al. Low molecular weight heparin in improving RAO after transradial coronary catheterization: the LOW-RAO randomized study. JACC Cardiovasc. Interv. 15, 1686\u20131688 (2022).","journal-title":"JACC Cardiovasc. Interv."},{"key":"111_CR118","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1161\/CIRCULATIONAHA.105.595397","volume":"112","author":"MS Sabatine","year":"2005","unstructured":"Sabatine, M. S. et al. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial. Circulation 112, 3846\u20133854 (2005).","journal-title":"Circulation"},{"key":"111_CR119","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1586\/14779072.5.3.387","volume":"5","author":"S Lee","year":"2007","unstructured":"Lee, S. & Gibson, C. M. Enoxaparin in acute coronary syndromes. Expert Rev. Cardiovasc. Ther. 5, 387\u2013399 (2007).","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"111_CR120","first-page":"45","volume":"292","author":"JJ Ferguson","year":"2004","unstructured":"Ferguson, J. J. et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 292, 45\u201354 (2004).","journal-title":"JAMA"},{"key":"111_CR121","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jjcc.2020.08.008","volume":"77","author":"M Nakamura","year":"2021","unstructured":"Nakamura, M. et al. Bleeding risks associated with anticoagulant therapies after percutaneous coronary intervention in Japanese patients with ischemic heart disease complicated by atrial fibrillation: a comparative study. J. Cardiol. 77, 186\u2013194 (2021).","journal-title":"J. Cardiol."},{"key":"111_CR122","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s40265-020-01345-5","volume":"80","author":"RM Crawley","year":"2020","unstructured":"Crawley, R. M. & Anderson, R. L. Prevention and treatment of bleeding with direct oral anticoagulants. Drugs 80, 1293\u20131308 (2020).","journal-title":"Drugs"},{"key":"111_CR123","unstructured":"Spadafora, L. et al. Impact of in-hospital bleeding on post-discharge therapies and prognosis in acute coronary syndromes. J. Cardiovasc. Pharmacol. 10, 1097 (2022)."},{"key":"111_CR124","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2018.01.040","volume":"71","author":"DJ Angiolillo","year":"2018","unstructured":"Angiolillo, D. J., Rollini, F. & Franchi, F. The quest for the optimal periprocedural antithrombotic treatment strategy in ACS patients undergoing PCI. J. Am. Coll. Cardiol. 71, 1243\u20131245 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"111_CR125","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1161\/CIRCULATIONAHA.123.063946","volume":"148","author":"B Bikdeli","year":"2023","unstructured":"Bikdeli, B. et al. Bivalirudin versus heparin during PCI in NSTEMI: individual patient data meta-analysis of large randomized trials. Circulation 148, 1207\u20131219 (2023).","journal-title":"Circulation"},{"key":"111_CR126","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/cce2.54","volume":"3","author":"PD Williams","year":"2017","unstructured":"Williams, P. D. & Awan, M. Stent selection for percutaneous coronary intervention. Continuing Cardiol. Educ. 3, 64\u201369 (2017).","journal-title":"Continuing Cardiol. Educ."},{"key":"111_CR127","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jacc.2007.06.047","volume":"50","author":"A Schomig","year":"2007","unstructured":"Schomig, A. et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J. Am. Coll. Cardiol. 50, 1373\u20131380 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"111_CR128","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jacc.2013.09.061","volume":"63","author":"T Palmerini","year":"2014","unstructured":"Palmerini, T. et al. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. J. Am. Coll. Cardiol. 63, 299\u2013307 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"111_CR129","first-page":"575","volume":"99","author":"A Saito","year":"2022","unstructured":"Saito, A. et al. The relationship between coronary stent strut thickness and the incidences of clinical outcomes after drug-eluting stent implantation: a systematic review and meta-regression analysis. Catheter. Cardiovasc. Inter. 99, 575\u2013582 (2022).","journal-title":"Catheter. Cardiovasc. Inter."},{"key":"111_CR130","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s10554-020-01876-8","volume":"36","author":"K Amemiya","year":"2020","unstructured":"Amemiya, K. et al. Chronic stent recoil in severely calcified coronary artery lesions. A serial optical coherence tomography study. Int. J. Cardiovasc. Imaging 36, 1617\u20131626 (2020).","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"111_CR131","doi-asserted-by":"publisher","first-page":"e008024","DOI":"10.1161\/CIRCINTERVENTIONS.119.008024","volume":"12","author":"JF Iglesias","year":"2019","unstructured":"Iglesias, J. F. et al. Long-Term effect of ultrathin-strut versus thin-strut drug-eluting stents in patients with small vessel coronary artery disease undergoing percutaneous coronary intervention: a subgroup Analysis of the BIOSCIENCE Randomized Trial. Circ. Cardiovasc. Interv. 12, e008024 (2019).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"111_CR132","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","volume":"123","author":"K Kolandaivelu","year":"2011","unstructured":"Kolandaivelu, K. et al. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation 123, 1400\u20131409 (2011).","journal-title":"Circulation"},{"key":"111_CR133","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.amjcard.2011.06.004","volume":"108","author":"R Al-Lamee","year":"2011","unstructured":"Al-Lamee, R. et al. Comparison of long-term clinical and angiographic outcomes following implantation of bare metal stents and drug-eluting stents in aorto-ostial lesions. Am. J. Cardiol. 108, 1055\u20131060 (2011).","journal-title":"Am. J. Cardiol."},{"key":"111_CR134","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ijcard.2017.10.066","volume":"254","author":"S Mitomo","year":"2018","unstructured":"Mitomo, S. et al. Comparison of mid-term clinical outcomes after treatment of ostial right coronary artery lesions with early and new generation drug-eluting stents: insights from an international multicenter registry. Int. J. Cardiol. 254, 53\u201358 (2018).","journal-title":"Int. J. Cardiol."},{"key":"111_CR135","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1056\/NEJMoa1610227","volume":"375","author":"GW Stone","year":"2016","unstructured":"Stone, G. W. et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N. Engl. J. Med. 375, 2223\u20132235 (2016).","journal-title":"N. Engl. J. Med."},{"key":"111_CR136","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/j.amjcard.2011.01.063","volume":"107","author":"R Valenti","year":"2011","unstructured":"Valenti, R. et al. Comparison of everolimus-eluting stent with paclitaxel-eluting stent in long chronic total occlusions. Am. J. Cardiol. 107, 1768\u20131771 (2011).","journal-title":"Am. J. Cardiol."},{"key":"111_CR137","first-page":"327","volume":"4","author":"F Burzotta","year":"2011","unstructured":"Burzotta, F. et al. Prospective randomized comparison of sirolimus-or everolimus-eluting stent to treat bifurcated lesions by provisional approach. JACC: Cardiovasc. Interv. 4, 327\u2013335 (2011).","journal-title":"JACC: Cardiovasc. Interv."},{"key":"111_CR138","first-page":"175","volume":"71","author":"Y Louvard","year":"2008","unstructured":"Louvard, Y. et al. Classification of coronary artery bifurcation lesions and treatments: time for a consensus!. Catheteri. Cardiovasc. Interv. 71, 175\u2013183 (2008).","journal-title":"Catheteri. Cardiovasc. Interv."},{"key":"111_CR139","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.4244\/EIJ-D-20-00169","volume":"16","author":"F Burzotta","year":"2021","unstructured":"Burzotta, F. et al. Percutaneous coronary intervention for bifurcation coronary lesions: the 15th consensus document from the European Bifurcation Club: 15th EBC consensus on bifurcation. EuroIntervention 16, 1307 (2021).","journal-title":"EuroIntervention"},{"key":"111_CR140","first-page":"346","volume":"96","author":"RF Riley","year":"2020","unstructured":"Riley, R. F. et al. SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease. Catheter. Cardiovasc. Inter. 96, 346\u2013362 (2020).","journal-title":"Catheter. Cardiovasc. Inter."},{"key":"111_CR141","first-page":"E375","volume":"92","author":"J Bennett","year":"2018","unstructured":"Bennett, J. et al. 5-year clinical follow-up of the COBRA (complex coronary bifurcation lesions: randomized comparison of a strategy using a dedicated self-expanding biolimus A9-eluting stent vs. a culotte strategy using everolimus-eluting stents) study. Catheter. Cardiovasc. Interv. 92, E375\u2013E380 (2018).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"111_CR142","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.4244\/EIJY15M05_02","volume":"11","author":"C Dubois","year":"2016","unstructured":"Dubois, C. et al. COmplex coronary Bifurcation lesions: RAndomized comparison of a strategy using a dedicated self-expanding biolimus-eluting stent versus a culotte strategy using everolimus-eluting stents: primary results of the COBRA trial. EuroIntervention 11, 1457\u20131467 (2016).","journal-title":"EuroIntervention"},{"key":"111_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75836-6","volume":"10","author":"P Gasior","year":"2020","unstructured":"Gasior, P. et al. Comparison of overexpansion capabilities and thrombogenicity at the side branch ostia after implantation of four different drug eluting stents. Sci. Rep. 10, 20791 (2020).","journal-title":"Sci. Rep."},{"key":"111_CR144","first-page":"1231","volume":"87","author":"P G\u00e9n\u00e9reux","year":"2016","unstructured":"G\u00e9n\u00e9reux, P. et al. Outcomes of a dedicated stent in coronary bifurcations with large side branches: a subanalysis of the randomized TRYTON bifurcation study. Catheter. Cardiovasc. Interv. 87, 1231\u20131241 (2016).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"111_CR145","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jacc.2014.11.031","volume":"65","author":"P G\u00e9n\u00e9reux","year":"2015","unstructured":"G\u00e9n\u00e9reux, P. et al. A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions. J. Am. Coll. Cardiol. 65, 533\u2013543 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"111_CR146","first-page":"1255","volume":"93","author":"M Konigstein","year":"2019","unstructured":"Konigstein, M. et al. Outcomes of the Tryton-dedicated bifurcation stent for the treatment of true coronary bifurcations: Individual-patient-data pooled analysis. Catheter. Cardiovasc. Interv. 93, 1255\u20131261 (2019).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"111_CR147","first-page":"761","volume":"8","author":"DE Kandzari","year":"2015","unstructured":"Kandzari, D. E. et al. Safety and effectiveness of everolimus-eluting stents in chronic total coronary occlusion revascularization: results from the EXPERT CTO multicenter trial (Evaluation of the XIENCE Coronary Stent, Performance, and Technique in Chronic Total Occlusions). Cardiovasc. Interv. 8, 761\u2013769 (2015).","journal-title":"Cardiovasc. Interv."},{"key":"111_CR148","first-page":"213","volume":"4","author":"Y Morino","year":"2011","unstructured":"Morino, Y. et al. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30\u2009min: the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool. JACC: Cardiovasc. Interv. 4, 213\u2013221 (2011).","journal-title":"JACC: Cardiovasc. Interv."},{"key":"111_CR149","first-page":"1","volume":"9","author":"G Christopoulos","year":"2016","unstructured":"Christopoulos, G. et al. Development and validation of a novel scoring system for predicting technical success of chronic total occlusion percutaneous coronary interventions: the PROGRESS CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) score. JACC: Cardiovasc. Interv. 9, 1\u20139 (2016).","journal-title":"JACC: Cardiovasc. Interv."},{"key":"111_CR150","first-page":"367","volume":"5","author":"ES Brilakis","year":"2012","unstructured":"Brilakis, E. S. et al. A percutaneous treatment algorithm for crossing coronary chronic total occlusions. JACC: Cardiovasc. Interv. 5, 367\u2013379 (2012).","journal-title":"JACC: Cardiovasc. Interv."},{"key":"111_CR151","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.jacc.2021.05.055","volume":"78","author":"EB Wu","year":"2021","unstructured":"Wu, E. B. et al. Global chronic total occlusion crossing algorithm: JACC state-of-the-art review. J. Am. Coll. Cardiol. 78, 840\u2013853 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"111_CR152","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/MCA.0000000000000924","volume":"31","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y., Peng, H., Li, X. & Liu, J. Procedural outcomes of chronic total occlusion percutaneous coronary intervention in patients with dissection and reentry versus wire escalation techniques: a meta-analysis. Coron. Artery Dis. 31, 703\u2013715 (2020).","journal-title":"Coron. Artery Dis."},{"key":"111_CR153","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4244\/EIJ-D-17-00867","volume":"14","author":"S Matsuno","year":"2018","unstructured":"Matsuno, S. et al. Overview and proposed terminology for the reverse controlled antegrade and retrograde tracking (reverse CART) techniques. EuroIntervention 14, 94\u2013101 (2018).","journal-title":"EuroIntervention"},{"key":"111_CR154","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1161\/CIRCULATIONAHA.112.000646","volume":"127","author":"JA Bittl","year":"2013","unstructured":"Bittl, J. A., He, Y., Jacobs, A. K., Yancy, C. W. & Normand, S.-L. T. Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease. Circulation 127, 2177\u20132185 (2013).","journal-title":"Circulation"},{"key":"111_CR155","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1213\/ANE.0b013e3182407c25","volume":"114","author":"LD Hillis","year":"2012","unstructured":"Hillis, L. D. et al. Special articles: 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Anesth. Analg. 114, 11\u201345 (2012).","journal-title":"Anesth. Analg."},{"key":"111_CR156","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.jacc.2017.02.001","volume":"69","author":"MR Patel","year":"2017","unstructured":"Patel, M. R. et al. ACC\/AATS\/AHA\/ASE\/ASNC\/SCAI\/SCCT\/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology appropriate use criteria task force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 69, 2212\u20132241 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"111_CR157","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","volume":"79","author":"WC Members","year":"2022","unstructured":"Members, W. C. et al. 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 79, e21\u2013e129 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"111_CR158","doi-asserted-by":"publisher","first-page":"e033929","DOI":"10.1161\/JAHA.123.033929","volume":"13","author":"D Zhang","year":"2024","unstructured":"Zhang, D. et al. Technological advances are associated with better clinical outcomes of percutaneous coronary intervention in patients with unprotected left main disease. J. Am. Heart Assoc. 13, e033929 (2024).","journal-title":"J. Am. Heart Assoc."},{"key":"111_CR159","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008325","volume":"13","author":"L Gaido","year":"2020","unstructured":"Gaido, L. et al. Impact of kissing balloon in patients treated with ultrathin stents for left main lesions and bifurcations: an analysis from the RAIN-CARDIOGROUP VII study. Circ. Cardiovasc. Interv. 13, e008325 (2020).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"111_CR160","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1161\/CIRCULATIONAHA.110.966879","volume":"123","author":"M Niemel\u00e4","year":"2011","unstructured":"Niemel\u00e4, M. et al. Randomized comparison of final kissing balloon dilatation versus no final kissing balloon dilatation in patients with coronary bifurcation lesions treated with main vessel stenting: the Nordic-Baltic Bifurcation Study III. Circulation 123, 79\u201386 (2011).","journal-title":"Circulation"},{"key":"111_CR161","first-page":"1297","volume":"8","author":"CW Yu","year":"2015","unstructured":"Yu, C. W. et al. Long-term clinical outcomes of final kissing ballooning in coronary bifurcation lesions treated with the 1-stent technique: results from the COBIS II Registry (Korean Coronary Bifurcation Stenting Registry). Cardiovasc. Interv. 8, 1297\u20131307 (2015).","journal-title":"Cardiovasc. Interv."},{"key":"111_CR162","doi-asserted-by":"publisher","first-page":"218","DOI":"10.4244\/EIJ-D-19-00851","volume":"16","author":"AS Kini","year":"2020","unstructured":"Kini, A. S. et al. Influence of final kissing balloon inflation on long-term outcomes after PCI of distal left main bifurcation lesions in the EXCEL trial. Eurointervention: 16, 218\u2013224 (2020).","journal-title":"Eurointervention:"},{"key":"111_CR163","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1016\/j.jacc.2017.09.1066","volume":"70","author":"H Zeng","year":"2017","unstructured":"Zeng, H. et al. Double kissing crush versus provisional stenting for left main distal bifurcation lesions. J. Am. Coll. Cardiol. 70, 2605\u20132617 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"111_CR164","first-page":"1927","volume":"12","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. 3-year outcomes of the DKCRUSH-V trial comparing DK crush with provisional stenting for left main bifurcation lesions. JACC: Cardiovasc. Interv. 12, 1927\u20131937 (2019).","journal-title":"JACC: Cardiovasc. Interv."},{"key":"111_CR165","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.jacc.2022.09.034","volume":"80","author":"LJ Davidson","year":"2022","unstructured":"Davidson, L. J. et al. A practical approach to left main coronary artery disease: JACC state-of-the-art review. J. Am. Coll. Cardiol. 80, 2119\u20132134 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"111_CR166","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.carrev.2020.06.018","volume":"22","author":"S Aoi","year":"2021","unstructured":"Aoi, S., Gonzalez, C., Chan, D. & Kwan, T. Transulnar catheterization in patients with failed ipsilateral transradial access: novel TR band modification for dual-site hemostasis. Cardiovasc. Revasc. Med. 22, 84\u201388 (2021).","journal-title":"Cardiovasc. Revasc. Med."},{"key":"111_CR167","first-page":"276","volume":"37","author":"S Lavi","year":"2021","unstructured":"Lavi, S. et al. Short durations of radial hemostatic device after diagnostic transradial cardiac catheterization: the PRACTICAL-2 randomized trial. Can. J. Cardiol. 37, 276\u2013283 (2021).","journal-title":"Can. J. Cardiol."},{"key":"111_CR168","doi-asserted-by":"publisher","first-page":"e042101","DOI":"10.1136\/bmjopen-2020-042101","volume":"10","author":"S Aijaz","year":"2020","unstructured":"Aijaz, S., Sheikh, S. & Pathan, A. Combination of InnoSEAL plus TR band compared with TR band alone for radial artery outcomes in patients undergoing transradial coronary intervention (InnoSEAL-II): an open-label randomised controlled trial (protocol). BMJ Open 10, e042101 (2020).","journal-title":"BMJ Open"},{"key":"111_CR169","first-page":"52","volume":"32","author":"HA Riyami","year":"2020","unstructured":"Riyami, H. A., Riyami, A. A. & Nadar, S. K. Comparison between two protocols for deflation of the TR band following coronary procedures via the radial route. J. Saudi Heart Assoc. 32, 52\u201356 (2020).","journal-title":"J. Saudi Heart Assoc."},{"key":"111_CR170","first-page":"e012781","volume":"16","author":"MH Maqsood","year":"2023","unstructured":"Maqsood, M. H. et al. Optimal hemostatic band duration after transradial angiography or intervention: insights from a mixed treatment comparison meta-analysis of randomized trials. Circ. Cardiovasc. Inter. 16, e012781 (2023).","journal-title":"Circ. Cardiovasc. Inter."},{"key":"111_CR171","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jacc.2020.11.013","volume":"77","author":"SV Rao","year":"2021","unstructured":"Rao, S. V. et al. 2021 ACC expert consensus decision pathway on same-day discharge after percutaneous coronary intervention. J. Am. Coll. Cardiol. 77, 811\u2013825 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"111_CR172","doi-asserted-by":"publisher","first-page":"e643","DOI":"10.4244\/EIJ-D-23-00838","volume":"20","author":"YBO Somsen","year":"2024","unstructured":"Somsen, Y. B. O. et al. Same-day discharge after large-bore access in percutaneous coronary intervention of chronic total coronary occlusions. EuroIntervention 20, e643\u2013e655 (2024).","journal-title":"EuroIntervention"},{"key":"111_CR173","first-page":"464","volume":"21","author":"R Glaser","year":"2009","unstructured":"Glaser, R. et al. Patient satisfaction is comparable to early discharge versus overnight observation after elective percutaneous coronary intervention. J. Invasive Cardiol. 21, 464\u2013467 (2009).","journal-title":"J. Invasive Cardiol."},{"key":"111_CR174","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jcin.2012.10.008","volume":"6","author":"E Abdelaal","year":"2013","unstructured":"Abdelaal, E. et al. Same-day discharge compared with overnight hospitalization after uncomplicated percutaneous coronary intervention: a systematic review and meta-analysis. JACC Cardiovasc Interv. 6, 99\u2013112 (2013).","journal-title":"JACC Cardiovasc Interv."},{"key":"111_CR175","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jacc.2013.03.051","volume":"62","author":"KM Brayton","year":"2013","unstructured":"Brayton, K. M., Patel, V. G., Stave, C., de Lemos, J. A. & Kumbhani, D. J. Same-day discharge after percutaneous coronary intervention: a meta-analysis. J. Am. Coll. Cardiol. 62, 275\u2013285 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"111_CR176","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1001\/jama.2014.3695","volume":"311","author":"AS Detsky","year":"2014","unstructured":"Detsky, A. S. & Krumholz, H. M. Reducing the trauma of hospitalization. JAMA 311, 2169\u20132170 (2014).","journal-title":"JAMA"},{"key":"111_CR177","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"F-J Neumann","year":"2019","unstructured":"Neumann, F.-J. et al. 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur. heart J. 40, 87\u2013165 (2019).","journal-title":"Eur. heart J."},{"key":"111_CR178","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMoa2208335","volume":"387","author":"D-W Park","year":"2022","unstructured":"Park, D.-W. et al. Routine functional testing or standard care in high-risk patients after PCI. N. Engl. J. Med. 387, 905\u2013915 (2022).","journal-title":"N. Engl. J. Med."},{"key":"111_CR179","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.tcm.2021.12.007","volume":"33","author":"M Galli","year":"2023","unstructured":"Galli, M., Franchi, F., Rollini, F. & Angiolillo, D. J. Role of platelet function and genetic testing in patients undergoing percutaneous coronary intervention. Trends Cardiovasc. Med. 33, 133\u2013138 (2023).","journal-title":"Trends Cardiovasc. Med."},{"key":"111_CR180","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/cts.13479","volume":"16","author":"JD Anderson","year":"2023","unstructured":"Anderson, J. D. et al. Pharmacogenetic actionability and medication prescribing in people with cystic fibrosis. Clin. Transl. Sci. 16, 662\u2013672 (2023).","journal-title":"Clin. Transl. Sci."},{"key":"111_CR181","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1161\/CIR.0000000000001257","volume":"150","author":"NL Pereira","year":"2024","unstructured":"Pereira, N. L. et al. CYP2C19 genetic testing for oral P2Y12 Inhibitor therapy: a scientific statement from the American Heart Association. Circulation 150, e129\u2013e150 (2024).","journal-title":"Circulation"},{"key":"111_CR182","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMoa0809171","volume":"360","author":"JL Mega","year":"2009","unstructured":"Mega, J. L. et al. Cytochrome p-450 polymorphisms and response to clopidogrel. N. Engl. J. Med. 360, 354\u2013362 (2009).","journal-title":"N. Engl. J. Med."},{"key":"111_CR183","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1001\/jama.2010.1543","volume":"304","author":"JL Mega","year":"2010","unstructured":"Mega, J. L. et al. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA 304, 1821\u20131830 (2010).","journal-title":"JAMA"},{"key":"111_CR184","doi-asserted-by":"publisher","first-page":"e024159","DOI":"10.1161\/JAHA.121.024159","volume":"11","author":"AL Beitelshees","year":"2022","unstructured":"Beitelshees, A. L. et al. CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention in diverse clinical settings. J. Am. Heart Assoc. 11, e024159 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"111_CR185","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMoa1907096","volume":"381","author":"DMF Claassens","year":"2019","unstructured":"Claassens, D. M. F. et al. A genotype-guided strategy for oral P2Y(12) inhibitors in primary PCI. N. Engl. J. Med. 381, 1621\u20131631 (2019).","journal-title":"N. Engl. J. Med."},{"key":"111_CR186","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/jama.2020.12443","volume":"324","author":"NL Pereira","year":"2020","unstructured":"Pereira, N. L. et al. Effect of Genotype-Guided Oral P2Y12 inhibitor selection vs conventional clopidogrel therapy on ischemic outcomes after percutaneous coronary intervention: the TAILOR-PCI randomized clinical trial. JAMA 324, 761\u2013771 (2020).","journal-title":"JAMA"},{"key":"111_CR187","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jcin.2023.01.356","volume":"16","author":"BS Ingraham","year":"2023","unstructured":"Ingraham, B. S. et al. Genetic-Guided Oral P2Y(12) Inhibitor selection and cumulative ischemic events after percutaneous coronary intervention. JACC Cardiovasc. Interv. 16, 816\u2013825 (2023).","journal-title":"JACC Cardiovasc. Interv."},{"key":"111_CR188","first-page":"181","volume":"11","author":"LH Cavallari","year":"2018","unstructured":"Cavallari, L. H. et al. Multisite investigation of outcomes with implementation of CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention. JACC: Cardiovasc. Interv. 11, 181\u2013191 (2018).","journal-title":"JACC: Cardiovasc. Interv."},{"key":"111_CR189","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/eurheartj\/ehab836","volume":"43","author":"M Galli","year":"2022","unstructured":"Galli, M. et al. Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials. Eur. heart J. 43, 959\u2013967 (2022).","journal-title":"Eur. heart J."},{"key":"111_CR190","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jtcvs.2016.07.044","volume":"152","author":"GN Levine","year":"2016","unstructured":"Levine, G. N. et al. 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task force on clinical practice guidelines. J. Thorac. Cardiovasc. Surg. 152, 1243\u20131275 (2016).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"111_CR191","first-page":"2639","volume":"17","author":"DJ Angiolillo","year":"2024","unstructured":"Angiolillo, D. J. et al. International consensus statement on platelet function and genetic testing in percutaneous coronary intervention. Cardiovasc. Interv. 17, 2639\u20132663 (2024).","journal-title":"Cardiovasc. Interv."},{"key":"111_CR192","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.jcin.2019.03.034","volume":"12","author":"D Sibbing","year":"2019","unstructured":"Sibbing, D. et al. Updated expert consensus statement on platelet function and genetic testing for guiding P2Y(12) receptor inhibitor treatment in percutaneous coronary intervention. JACC Cardiovasc. Inter. 12, 1521\u20131537 (2019).","journal-title":"JACC Cardiovasc. Inter."},{"key":"111_CR193","doi-asserted-by":"publisher","first-page":"561","DOI":"10.4244\/EIJ-D-20-00873","volume":"17","author":"S Verheye","year":"2021","unstructured":"Verheye, S. et al. Coronary sinus narrowing for the treatment of refractory angina: a multicentre prospective open-label clinical study (the REDUCER-I study). EuroIntervention 17, 561\u2013568 (2021).","journal-title":"EuroIntervention"},{"key":"111_CR194","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1056\/NEJMoa1402556","volume":"372","author":"S Verheye","year":"2015","unstructured":"Verheye, S. et al. Efficacy of a device to narrow the coronary sinus in refractory angina. N. Engl. J. Med. 372, 519\u2013527 (2015).","journal-title":"N. Engl. J. Med."},{"key":"111_CR195","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijcard.2021.05.034","volume":"337","author":"F Ponticelli","year":"2021","unstructured":"Ponticelli, F. et al. Safety and efficacy of coronary sinus narrowing in chronic refractory angina: insights from the RESOURCE study. Int. J. Cardiol. 337, 29\u201337 (2021).","journal-title":"Int. J. Cardiol."},{"key":"111_CR196","first-page":"e013302","volume":"17","author":"S Korjian","year":"2024","unstructured":"Korjian, S. et al. Drug-coated balloons in the management of coronary artery disease. Circ. Cardiovasc. Inter. 17, e013302 (2024).","journal-title":"Circ. Cardiovasc. Inter."},{"key":"111_CR197","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(18)31719-7","volume":"392","author":"RV Jeger","year":"2018","unstructured":"Jeger, R. V. et al. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet 392, 849\u2013856 (2018).","journal-title":"Lancet"},{"key":"111_CR198","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0140-6736(19)31126-2","volume":"394","author":"TT Rissanen","year":"2019","unstructured":"Rissanen, T. T. et al. Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial. Lancet 394, 230\u2013239 (2019).","journal-title":"Lancet"},{"key":"111_CR199","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jacc.2019.12.046","volume":"75","author":"C Yerasi","year":"2020","unstructured":"Yerasi, C. et al. Drug-coated balloon for de novo coronary artery disease: JACC state-of-the-art review. J. Am. Coll. Cardiol. 75, 1061\u20131073 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"111_CR200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2024.07.016","volume":"277","author":"D Erlinge","year":"2024","unstructured":"Erlinge, D. et al. Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent. Am. Heart J. 277, 1\u201310 (2024).","journal-title":"Am. Heart J."},{"key":"111_CR201","doi-asserted-by":"publisher","first-page":"E974","DOI":"10.4244\/EIJ-D-20-00763","volume":"16","author":"S Verheye","year":"2020","unstructured":"Verheye, S. et al. Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system. EuroIntervention 16, E974 (2020).","journal-title":"EuroIntervention"},{"key":"111_CR202","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/S0140-6736(24)00282-4","volume":"403","author":"X Li","year":"2024","unstructured":"Li, X. et al. Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial. Lancet 403, 1855\u20131865 (2024).","journal-title":"Lancet"},{"key":"111_CR203","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08056-0","volume":"7","author":"J Bec","year":"2017","unstructured":"Bec, J. et al. In vivo label-free structural and biochemical imaging of coronary arteries using an integrated ultrasound and multispectral fluorescence lifetime catheter system. Sci. Rep. 7, 8960 (2017).","journal-title":"Sci. Rep."},{"key":"111_CR204","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01649-9","volume":"7","author":"J Hui","year":"2017","unstructured":"Hui, J. et al. Real-time intravascular photoacoustic-ultrasound imaging of lipid-laden plaque in human coronary artery at 16 frames per second. Sci. Rep. 7, 1417 (2017).","journal-title":"Sci. Rep."},{"key":"111_CR205","doi-asserted-by":"publisher","first-page":"452","DOI":"10.4244\/EIJ-D-19-00318","volume":"15","author":"S Iskander-Rizk","year":"2019","unstructured":"Iskander-Rizk, S. et al. In vivo intravascular photoacoustic imaging of plaque lipid in coronary atherosclerosis. EuroIntervention 15, 452\u2013456 (2019).","journal-title":"EuroIntervention"},{"key":"111_CR206","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74264-w","volume":"10","author":"W Wu","year":"2020","unstructured":"Wu, W. et al. 3D reconstruction of coronary artery bifurcations from coronary angiography and optical coherence tomography: feasibility, validation, and reproducibility. Sci. Rep. 10, 18049 (2020).","journal-title":"Sci. Rep."},{"key":"111_CR207","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1109\/TVCG.2021.3106478","volume":"27","author":"S Li","year":"2021","unstructured":"Li, S., Cui, J., Hao, A., Zhang, S. & Zhao, Q. Design and evaluation of personalized percutaneous coronary intervention surgery simulation system. IEEE Trans. Vis. Comput. Graph. 27, 4150\u20134160 (2021).","journal-title":"IEEE Trans. Vis. Comput. Graph."},{"key":"111_CR208","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.3390\/jcm13154368","volume":"13","author":"M Annabestani","year":"2024","unstructured":"Annabestani, M., Olyanasab, A. & Mosadegh, B. Application of mixed\/augmented reality in interventional cardiology. J. Clin. Med. 13, 4368 (2024).","journal-title":"J. Clin. Med."},{"key":"111_CR209","first-page":"519","volume":"15","author":"C Jung","year":"2022","unstructured":"Jung, C. et al. Virtual and augmented reality in cardiovascular care: state-of-the-art and future perspectives. Cardiovasc. Imaging 15, 519\u2013532 (2022).","journal-title":"Cardiovasc. Imaging"},{"key":"111_CR210","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1093\/eurheartj\/ehad352","volume":"44","author":"T-Y Tsai","year":"2023","unstructured":"Tsai, T.-Y. et al. Merging virtual and physical experiences: extended realities in cardiovascular medicine. Eur. Heart J. 44, 3311\u20133322 (2023).","journal-title":"Eur. Heart J."}],"container-title":["npj Cardiovascular Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44325-026-00111-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44325-026-00111-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44325-026-00111-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:04:07Z","timestamp":1774307047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44325-026-00111-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":210,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["111"],"URL":"https:\/\/doi.org\/10.1038\/s44325-026-00111-y","relation":{},"ISSN":["2948-2836"],"issn-type":[{"value":"2948-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Krittanawong is the founder of HumanX, a company that focuses on artificial intelligence in precision medicine and innovation in healthcare; he declares that his affiliation with HumanX is not a competing interest. Dr. Nanna reports unrelated research funding from the American College of Cardiology (George F and Ann Harris Bellows Foundation), the Patient-Centered Outcomes Research Institute, the Yale Claude D. Pepper Older Americans Independence Center (P30AG021342), and the National Institute on Aging\/National Institutes of Health (K76AG088428). Dr. Nanna also reports personal fees from HeartFlow, Novo Nordisk, and Merck. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}